BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Güder G, Störk S, Gelbrich G, Brenner S, Deubner N, Morbach C, Wallenborn J, Berliner D, Ertl G, Angermann CE. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling: Nurse-coordinated disease management improves therapy and outcomes in HF. Eur J Heart Fail 2015;17:442-52. [DOI: 10.1002/ejhf.252] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Peters S, Sukumar K, Blanchard S, Ramasamy A, Malinowski J, Ginex P, Senerth E, Corremans M, Munn Z, Kredo T, Remon LP, Ngeh E, Kalman L, Alhabib S, Amer YS, Gagliardi A. Trends in guideline implementation: an updated scoping review. Implementation Sci 2022;17. [DOI: 10.1186/s13012-022-01223-6] [Reference Citation Analysis]
2 Sekaran NK, Crowley AL, de Souza FR, Resende ES, Rao SV. The Role for Cardiovascular Remodeling in Cardiovascular Outcomes. Curr Atheroscler Rep 2017;19. [DOI: 10.1007/s11883-017-0656-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
3 Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Database Syst Rev 2016;11:CD011227. [PMID: 27873322 DOI: 10.1002/14651858.CD011227.pub2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
4 Metra M, Carubelli V, Ravera A, Stewart Coats AJ. Heart failure 2016: still more questions than answers. Int J Cardiol 2017;227:766-77. [PMID: 27838123 DOI: 10.1016/j.ijcard.2016.10.060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
5 Ajayi AA, Sofowora GG, Ladipo GO. Explaining Heart Failure Hyper-mortality in Sub Saharan Africa: Global Genomic and Environmental Contribution Review. J Natl Med Assoc 2020;112:141-57. [PMID: 32165009 DOI: 10.1016/j.jnma.2020.02.003] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Metra M. November 2017 at a glance: quality of care and disease management. Eur J Heart Fail 2017;19:1351-2. [PMID: 29143470 DOI: 10.1002/ejhf.1074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Gilbert EM, Xu WD. Rationales and choices for the treatment of patients with NYHA class II heart failure. Postgrad Med 2017;129:619-31. [PMID: 28670961 DOI: 10.1080/00325481.2017.1344082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 Packer M. Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparators. Int J Cardiol 2018;261:130-3. [PMID: 29548536 DOI: 10.1016/j.ijcard.2018.03.034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
9 Veenis JF, Brunner-La Rocca HP, Linssen GCM, Van Gent MWF, Hoes AW, Brugts JJ; CHECK-HF Investigators. Treatment Differences in Chronic Heart Failure Patients With Reduced Ejection Fraction According to Blood Pressure. Circ Heart Fail 2020;13:e006667. [PMID: 32370547 DOI: 10.1161/CIRCHEARTFAILURE.119.006667] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Saitoh M, Ishida J, Doehner W, von Haehling S, Anker MS, Coats AJS, Anker SD, Springer J. Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016. Int J Cardiol 2017;238:5-11. [PMID: 28427849 DOI: 10.1016/j.ijcard.2017.03.155] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 8.6] [Reference Citation Analysis]
11 Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JG. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 2015;:CD007228. [PMID: 26517969 DOI: 10.1002/14651858.CD007228.pub3] [Cited by in Crossref: 92] [Cited by in F6Publishing: 96] [Article Influence: 13.1] [Reference Citation Analysis]
12 Brennan EJ. Chronic heart failure nursing: integrated multidisciplinary care. Br J Nurs 2018;27:681-8. [DOI: 10.12968/bjon.2018.27.12.681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
13 Morbach C, Wagner M, Güntner S, Malsch C, Oezkur M, Wood D, Kotseva K, Leyh R, Ertl G, Karmann W, Heuschmann PU, Störk S. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort. BMC Cardiovasc Disord 2017;17:108. [PMID: 28476146 DOI: 10.1186/s12872-017-0543-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Ouwerkerk W, Voors A, Anker S, Cleland J, Dickstein K, Filippatos G, van der Harst P, Hillege H, Lang C, ter Maaten J, Ng L, Ponikowski P, Samani N, van Veldhuisen D, Zannad F, Metra M, Zwinderman A. Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study. European Heart Journal 2017;38:1883-90. [DOI: 10.1093/eurheartj/ehx026] [Cited by in Crossref: 175] [Cited by in F6Publishing: 140] [Article Influence: 35.0] [Reference Citation Analysis]
15 Alberto Neder J, O'Donnell DE. Heart, lungs, and muscle interplay in worsening activity-related breathlessness in advanced cardiopulmonary disease. Curr Opin Support Palliat Care 2020;14:157-66. [PMID: 32740275 DOI: 10.1097/SPC.0000000000000516] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Duncker D, König T, Hohmann S, Bauersachs J, Veltmann C. Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study. J Am Heart Assoc 2017;6:e004512. [PMID: 28096098 DOI: 10.1161/JAHA.116.004512] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
17 Bargoin M, Rey P, Maffre N, Hudde T, Sérange E, Chalard N, Guérin B, Moluçon Chabrot C, Collombet-Migeon F, Bay JO, Bahadoor MRK. [Place of coordination of complex pathways in oncology by coordinating private nurses]. Bull Cancer 2021;108:686-95. [PMID: 34049669 DOI: 10.1016/j.bulcan.2021.03.016] [Reference Citation Analysis]
18 Ferrari R, Bueno H, Chioncel O, Cleland JG, Stough WG, Lettino M, Metra M, Parissis JT, Pinto F, Ponikowski P, Ruschitzka F, Tavazzi L. Acute heart failure: lessons learned, roads ahead: Viewpoint. Eur J Heart Fail 2018;20:842-50. [DOI: 10.1002/ejhf.1169] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
19 Driscoll A, Currey J, Tonkin A, Krum H. Nurse-led titration of angiotensin converting enzyme inhibitors, beta-adrenergic blocking agents, and angiotensin receptor blockers for people with heart failure with reduced ejection fraction. Cochrane Database Syst Rev 2015;:CD009889. [PMID: 26689943 DOI: 10.1002/14651858.CD009889.pub2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
20 Morbach C, Marx A, Kaspar M, Güder G, Brenner S, Feldmann C, Störk S, Vollert JO, Ertl G, Angermann CE; INH Study Group and the Competence Network Heart Failure. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides. Eur J Heart Fail 2017;19:1166-75. [PMID: 28516504 DOI: 10.1002/ejhf.859] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
21 Laurent J, Le Cossec C, de Chambine S. [Nursing coordination in chronic diseases: The situation of activities in the Assistance Publique-Hôpitaux de Paris adult medicine units]. Rech Soins Infirm 2019;:90-8. [PMID: 31210505 DOI: 10.3917/rsi.136.0090] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Albert J, Lezius S, Störk S, Morbach C, Güder G, Frantz S, Wegscheider K, Ertl G, Angermann CE. Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes. J Am Heart Assoc 2021;10:e017822. [PMID: 33496189 DOI: 10.1161/JAHA.120.017822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Brandstetter C, Winter T, Weidinger F, Stöllberger C. The attitude towards disease management programs in Austrian heart failure patients: a pilot study comparing rural and urban patients. Minerva Cardioangiol 2020;68:209-15. [PMID: 32100981 DOI: 10.23736/S0026-4725.20.05082-3] [Reference Citation Analysis]
24 Wideqvist M, Cui X, Magnusson C, Schaufelberger M, Fu M. Hospital readmissions of patients with heart failure from real world: timing and associated risk factors. ESC Heart Fail 2021;8:1388-97. [PMID: 33599109 DOI: 10.1002/ehf2.13221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Walgraeve K, Van der Linden L, Flamaing J, Fagard K, Spriet I, Tournoy J. Feasibility of optimizing pharmacotherapy in heart failure patients admitted to an acute geriatric ward: role of the clinical pharmacist. Eur Geriatr Med 2018;9:103-11. [PMID: 34654283 DOI: 10.1007/s41999-017-0019-x] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
26 Ertl G, Brenner S, Angermann CE. [Cardiac remodeling after myocardial infarction : Clinical practice update]. Herz 2017;42:107-20. [PMID: 28105480 DOI: 10.1007/s00059-016-4530-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
27 Rosano GMC, Moura B, Metra M, Böhm M, Bauersachs J, Ben Gal T, Adamopoulos S, Abdelhamid M, Bistola V, Čelutkienė J, Chioncel O, Farmakis D, Ferrari R, Filippatos G, Hill L, Jankowska EA, Jaarsma T, Jhund P, Lainscak M, Lopatin Y, Lund LH, Milicic D, Mullens W, Pinto F, Ponikowski P, Savarese G, Thum T, Volterrani M, Anker SD, Seferovic PM, Coats AJS. Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2021;23:872-81. [PMID: 33932268 DOI: 10.1002/ejhf.2206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Oyanguren J, García-Garrido L, Nebot Margalef M, Lekuona I, Comin-Colet J, Manito N, Roure J, Ruiz Rodriguez P, Enjuanes C, Latorre P, Torcal Laguna J, García-Gutiérrez S; ETIFIC7 research group. Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol. ESC Heart Fail 2017;4:507-19. [PMID: 29154427 DOI: 10.1002/ehf2.12152] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
29 Young S. An overview of current treatments in heart failure. British Journal of Cardiac Nursing 2017;12:120-7. [DOI: 10.12968/bjca.2017.12.3.120] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Shanbhag D, Graham ID, Harlos K, Haynes RB, Gabizon I, Connolly SJ, Van Spall HGC. Effectiveness of implementation interventions in improving physician adherence to guideline recommendations in heart failure: a systematic review. BMJ Open 2018;8:e017765. [DOI: 10.1136/bmjopen-2017-017765] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
31 Harjola V, Parissis J, Bauersachs J, Brunner‐la Rocca H, Bueno H, Čelutkienė J, Chioncel O, Coats AJ, Collins SP, Boer RA, Filippatos G, Gayat E, Hill L, Laine M, Lassus J, Lommi J, Masip J, Mebazaa A, Metra M, Miró Ò, Mortara A, Mueller C, Mullens W, Peacock WF, Pentikäinen M, Piepoli MF, Polyzogopoulou E, Rudiger A, Ruschitzka F, Seferovic P, Sionis A, Teerlink JR, Thum T, Varpula M, Weinstein JM, Yilmaz MB. Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2020;22:1298-314. [DOI: 10.1002/ejhf.1831] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
32 Atherton JJ, Hickey A. Expert Comment: Is Medication Titration in Heart Failure too Complex? Card Fail Rev 2017;3:25-32. [PMID: 28785472 DOI: 10.15420/cfr.2017:1:2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
33 Güder G, Störk S. COPD and heart failure: differential diagnosis and comorbidity. Herz 2019;44:502-8. [PMID: 31111162 DOI: 10.1007/s00059-019-4814-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
34 Metra M. July 2016 at a glance: the critical role of co-morbidities. Eur J Heart Fail 2016;18:735-735. [DOI: 10.1002/ejhf.620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Pfister R, Ihle P, Mews B, Kohnen E, Wähner M, Karbach U, Aslan H, Höpp HW, Schneider CA. Feasibility of including patients with migration background in a structured heart failure management programme: A prospective case-control study exemplarily on Turkish migrants. PLoS One 2017;12:e0187358. [PMID: 29117200 DOI: 10.1371/journal.pone.0187358] [Reference Citation Analysis]
36 Rocha BML, Menezes Falcão L. Acute decompensated heart failure (ADHF): A comprehensive contemporary review on preventing early readmissions and postdischarge death. Int J Cardiol 2016;223:1035-44. [PMID: 27592046 DOI: 10.1016/j.ijcard.2016.07.259] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
37 Palin V, Drozd M, Garland E, Malik A, Straw S, McGinlay M, Simms A, Gatenby VK, Sengupta A, Levelt E, Witte KK, Kearney MT, Cubbon RM. Reduction of heart failure guideline-directed medication during hospitalization: prevalence, risk factors, and outcomes. ESC Heart Fail 2022. [PMID: 35796239 DOI: 10.1002/ehf2.14051] [Reference Citation Analysis]
38 Takeda A, Martin N, Taylor RS, Taylor SJ. Disease management interventions for heart failure. Cochrane Database Syst Rev 2019;1:CD002752. [PMID: 30620776 DOI: 10.1002/14651858.CD002752.pub4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
39 Neder JA, Rocha A, Alencar MCN, Arbex F, Berton DC, Oliveira MF, Sperandio PA, Nery LE, O'Donnell DE. Current challenges in managing comorbid heart failure and COPD. Expert Rev Cardiovasc Ther 2018;16:653-73. [PMID: 30099925 DOI: 10.1080/14779072.2018.1510319] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
40 Osteresch R, Fach A, Schmucker J, Eitel I, Langer H, Hambrecht R, Wienbergen H. Long-Term Risk Factor Control After Myocardial Infarction-A Need for Better Prevention Programmes. J Clin Med 2019;8:E1114. [PMID: 31357619 DOI: 10.3390/jcm8081114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
41 Harjola VP, Parissis J, Brunner-La Rocca HP, Čelutkienė J, Chioncel O, Collins SP, De Backer D, Filippatos GS, Gayat E, Hill L, Lainscak M, Lassus J, Masip J, Mebazaa A, Miró Ò, Mortara A, Mueller C, Mullens W, Nieminen MS, Rudiger A, Ruschitzka F, Seferovic PM, Sionis A, Vieillard-Baron A, Weinstein JM, de Boer RA, Crespo-Leiro MG, Piepoli M, Riley JP. Comprehensive in-hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail 2018;20:1081-99. [PMID: 29710416 DOI: 10.1002/ejhf.1204] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
42 Störk S, Handrock R, Jacob J, Walker J, Calado F, Lahoz R, Hupfer S, Klebs S. Treatment of chronic heart failure in Germany: a retrospective database study. Clin Res Cardiol 2017;106:923-32. [PMID: 28748266 DOI: 10.1007/s00392-017-1138-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
43 Hill L, Lambrinou E, Antoniou S. Optimizing evidence-based heart failure medication: every contact counts. Eur J Heart Fail 2021;23:1202-4. [PMID: 33932310 DOI: 10.1002/ejhf.2213] [Reference Citation Analysis]
44 Nauta JF, Santema BT, van der Wal MHL, Koops A, Warink-Riemersma J, van Dijk K, Inkelaar F, Prückl S, Suwijn J, van Deursen VM, Meijers WC, Coster J, Westenbrink BD, de Boer RA, Hummel Y, van Melle J, van Veldhuisen DJ, van der Meer P, Voors AA. Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction. Neth Heart J 2021;29:383-93. [PMID: 34125353 DOI: 10.1007/s12471-021-01591-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]